Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Textual)

v3.7.0.1
Subsequent Events (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 5 Months Ended 12 Months Ended
May 02, 2016
Mar. 22, 2017
Feb. 09, 2017
May 31, 2016
Mar. 31, 2017
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Subsequent Event [Line Items]                
Stock Issued During Period, Shares, New Issues 234,297              
Debt Conversion, Converted Instrument, Shares Issued       1,166,503     910,095  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       107,802        
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 7.50        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             460,000 200,000
Proceeds from Issuance Initial Public Offering           $ 1,600 $ 9,170,077  
Debt Conversion, Converted Instrument, Amount           $ 0 $ 363,792  
Subsequent Event [Member] | Science Advisory Board One [Member] | Employee Stock Option [Member]                
Subsequent Event [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         10,000      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price         $ 2.31      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         3 years      
Subsequent Event [Member] | Science Advisory Board Two [Member] | Employee Stock Option [Member]                
Subsequent Event [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         10,000      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price         $ 2.31      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         3 years      
Subsequent Event [Member] | Underwriting Agreement [Member]                
Subsequent Event [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     556,500          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.001          
Number Of Units issued     3,710,000          
Price Per Unit     $ 1.35          
Sale of Stock, Description of Transaction     purchase one share of common stock, and (iv) a five-year Series C warrant to purchase 0.50 of a share of common stock.          
Class Of Warrant Or Rights Warrant Exercised     278,100          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     556,500          
Share Price     $ 1.349          
Proceeds from Issuance Initial Public Offering     $ 4,400,000          
Subsequent Event [Member] | Underwriting Agreement [Member] | Series A Warrant [Member]                
Subsequent Event [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     278,250          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 1.50          
Subsequent Event [Member] | Underwriting Agreement [Member] | Series B Warrant [Member]                
Subsequent Event [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     556,500          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 1.35          
Subsequent Event [Member] | Underwriting Agreement [Member] | Series C Warrant [Member]                
Subsequent Event [Line Items]                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     278,250          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 1.50          
Subsequent Event [Member] | Former Science Advisory Board [Member]                
Subsequent Event [Line Items]                
Debt Conversion, Converted Instrument, Shares Issued         79,167      
Debt Conversion, Converted Instrument, Amount         $ 237,500      
Subsequent Event [Member] | U.S. Food and Drug Administration [Member]                
Subsequent Event [Line Items]                
Stock Issued During Period, Shares, New Issues   600,000            
Proceeds from Issuance of Warrants   $ 800,000            
Subsequent Event [Member] | U.S. Food and Drug Administration [Member] | Series B Warrant [Member]                
Subsequent Event [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised   600,000